Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: A Bidirectional Relationship

被引:61
|
作者
Muzica, Cristina M. [1 ,2 ]
Sfarti, Catalin [1 ,2 ]
Trifan, Anca [1 ,2 ]
Zenovia, Sebastian [1 ,2 ]
Cuciureanu, Tudor [1 ,2 ]
Nastasa, Robert [1 ,2 ]
Huiban, Laura [1 ,2 ]
Cojocariu, Camelia [1 ,2 ]
Singeap, Ana-Maria [1 ,2 ]
Girleanu, Irina [1 ,2 ]
Chiriac, Stefan [1 ,2 ]
Stanciu, Carol [2 ]
机构
[1] Grigore T Popa Univ Med & Pharm, Dept Gastroenterol, Iasi 700115, Romania
[2] St Spiridon Emergency Hosp, Iasi 700115, Romania
关键词
GAMMA-GLUTAMYL-TRANSFERASE; INSULIN-RESISTANCE; CARDIOVASCULAR-DISEASE; AMINOTRANSFERASE LEVELS; METABOLIC SYNDROME; RISK-FACTORS; FOLLOW-UP; ASSOCIATION; NAFLD; STEATOHEPATITIS;
D O I
10.1155/2020/6638306
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Worldwide, the leading cause of chronic liver disease is represented by nonalcoholic fatty liver disease (NAFLD) which has now become a global epidemic of the 21st century, affecting 1 in 4 adults, and which appears to be associated with the steadily increasing rates of metabolic syndrome and its components (obesity, type 2 diabetes mellitus (T2DM), and dyslipidemia). NAFLD has been reported to be associated with extrahepatic manifestations such as cardiovascular disease, T2DM, chronic kidney disease, extrahepatic malignancies (e.g., colorectal cancer), endocrine diseases (e.g., hypothyroidism, polycystic ovarian syndrome, psoriasis, and osteoporosis), obstructive sleep apnea, and iron overload. The prevalence of NAFLD is very high, affecting 25-30% of the world population and encloses two steps: (1) nonalcoholic fatty liver (NAFL), which includes steatosis only, and (2) nonalcoholic steatohepatitis (NASH) defined by the presence of steatosis and inflammation with hepatocyte ballooning, with or without fibrosis which can progress to liver fibrosis, hepatocellular carcinoma, and liver transplantation. Current data define a more complex relationship between NAFLD and T2DM than was previously believed, underlining a bidirectional and mutual association between the two entities. This review aims to summarize the current literature regarding the incidence of T2DM among patients with NAFLD and also the prevalence of NAFLD in T2DM patients, highlighting the recent key studies. Clinicians should screen, diagnose, and treat T2DM in patients with NAFLD in order to avoid short- and long-term complications.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] The Perirenal Fat Thickness Was Associated with Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus
    Yang, Yuxian
    Li, Shuting
    Xu, Yuechao
    Ke, Jing
    Zhao, Dong
    DIABETES METABOLIC SYNDROME AND OBESITY, 2022, 15 : 1505 - 1515
  • [42] The effect of metformin on leptin in obese patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease
    Nar, A.
    Gedik, O.
    ACTA DIABETOLOGICA, 2009, 46 (02) : 113 - 118
  • [43] Hepatotoxicity Associated with Metformin Therapy in Treatment of Type 2 Diabetes Mellitus with Nonalcoholic Fatty Liver Disease
    Cone, Catherine J.
    Bachyrycz, Amy M.
    Murata, Glen H.
    ANNALS OF PHARMACOTHERAPY, 2010, 44 (10) : 1655 - 1659
  • [44] An insight on the additive impact of type 2 diabetes mellitus and nonalcoholic fatty liver disease on cardiovascular consequences
    Bhardwaj, Monika
    Mazumder, Papiya Mitra
    MOLECULAR BIOLOGY REPORTS, 2025, 52 (01)
  • [45] Association between triglyceride–glucose index and nonalcoholic fatty liver disease in type 2 diabetes mellitus
    Wei Li
    Yan Wang
    Feng He
    Zhuo Liu
    Jie Dong
    Yuqi Zhang
    Tianfang Li
    Shengyun Liu
    En Chen
    BMC Endocrine Disorders, 22
  • [46] The effect of metformin on leptin in obese patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease
    A. Nar
    O. Gedik
    Acta Diabetologica, 2009, 46 : 113 - 118
  • [47] Prevalence of nonalcoholic fatty liver disease and its association with age in patients with type 2 diabetes mellitus
    Yamane, Ryosuke
    Yoshioka, Kentaro
    Hayashi, Kazuhiko
    Shimizu, Yuko
    Ito, Yuki
    Matsushita, Komei
    Yoshizaki, Michiyo
    Kajikawa, Go
    Mizutani, Taro
    Watarai, Atsuko
    Tachi, Kosuke
    Goto, Hidemi
    WORLD JOURNAL OF HEPATOLOGY, 2022, 14 (06) : 1226 - 1234
  • [48] Main Risk Factors of Type 2 Diabetes Mellitus with Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma
    Qi, Yueying
    Fan, Lirong
    Ran, Decong
    Xu, Jieda
    Wang, Yuansong
    Wu, Jin
    Zhang, Zhongyong
    JOURNAL OF ONCOLOGY, 2021, 2021
  • [49] Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus A meta-analysis
    Dai, Wenjie
    Ye, Ling
    Liu, Aizhong
    Wen, Shi Wu
    Deng, Jing
    Wu, Xin
    Lai, Zhiwei
    MEDICINE, 2017, 96 (39)
  • [50] Nonalcoholic Fatty Liver Disease Is Associated with Aortic Valve Sclerosis in Patients with Type 2 Diabetes Mellitus
    Bonapace, Stefano
    Valbusa, Filippo
    Bertolini, Lorenzo
    Pichiri, Isabella
    Mantovani, Alessandro
    Rossi, Andrea
    Zenari, Luciano
    Barbieri, Enrico
    Targher, Giovanni
    PLOS ONE, 2014, 9 (02):